|
New from
CDC Authors
Condom Use among Women of Reproductive Age (18-49
years) in Puerto Rico During the 2016 Zika Virus (ZIKV) Outbreak: Secondary
Analysis of Data from a Cross-sectional, Population-based, Cell-phone
Survey
Contraception is a medical
countermeasure to reduce unintended pregnancy and ZIKV-associated birth
defects. We estimated the prevalence of condom use and associated factors
among women at risk for unintended pregnancy in Puerto Rico during the 2016
ZIKV outbreak.
Genital Microbiota of Women Using a 90 Day
Tenofovir or Tenofovir and Levonorgestrel Intravaginal Ring in a Placebo
Controlled Randomized Safety Trial in Kenya
Intravaginal rings (IVRs) are a
safe, discreet and effective option for simultaneous delivery of
contraception and antiretrovirals. In a phase-IIa trial, study authors
investigated the influence of 90 days continuous-delivery tenofovir (TFV)
IVRs with/without levonorgestrel (LNG) on the genital microbiota of Kenyan
women. Microbiota shifts could influence genital health and ability of the
female genital tract to protect against infections including sexually
transmitted infections.
Human Papillomavirus Vaccine Beliefs and Practice
Characteristics in Rural and Urban Adolescent Care Providers
The human papillomavirus (HPV)
vaccine is recommended for all adolescents age 11-12 years. HPV vaccine
coverage remains suboptimal in the United States though, particularly in
rural areas. This study surveyed adolescent immunization providers in two
Midwestern states to assess rural vs. urban differences in HPV vaccine
resources, practices, and attitudes.
A Risk Measurement Tool for Targeted HIV Prevention
Measures amongst Young Pregnant and Lactating Women in South Africa
The progress made towards
reducing AIDS-related deaths has not been matched with equal progress in
reducing new HIV infections. Young women ages 15-24 years continue to
account for a disproportionate number of new infections. This study aimed
to develop and validate a tool to identify which pregnant/lactating young
South African women (≤ 24 years) are at risk of HIV infection.
Risk-Based Cervical Consensus Guidelines: Methods
to Determine Management if Less Than 5 Years of Data Are Available
In the 2019 American Society
for Colposcopy and Cervical Pathology Risk-Based Management Consensus
Guidelines, clinical management decisions are based on immediate and 5-year
cervical intraepithelial neoplasia (CIN) 3+ risk estimates. However, data
for technologies other than human papillomavirus testing and cytology may
be limited to clinical trials and observational studies of shorter duration
than 5 years. In this study, to enable decisions about 1- or 3-year
intervals, 3-year CIN 3+ risk equivalents to 5-year CIN 3+ risk thresholds
were generated.
Progress Towards the UNAIDS 95-95-95 Targets
among Pregnant Women in South Africa: Results from the 2017 and 2019
National Antenatal HIV Sentinel Surveys
The UNAIDS 95-95-95 global
targets for epidemic control aim to ensure by 2030 that 95% of HIV-positive
people know their HIV status, 95% of people diagnosed with HIV receive
sustained antiretroviral therapy (ART), and 95% of people on ART have viral
suppression. This study assessed progress towards the 95-95-95 targets
among pregnant women between the ages of 15-49 years attending public
health facilities in South Africa.
New from
CDC Authors: COVID-19 Impact on Women
Gestational SARS-CoV-2 Infection is Associated
with Placental Expression of Immune and Trophoblast Genes
Maternal SARS-CoV-2 infection
during pregnancy is associated with adverse pregnancy outcomes and can have
effects on the placenta, even in the absence of severe disease or vertical
transmission to the fetus. This study aimed to evaluate histopathologic and
molecular effects in the placenta after SARS-CoV-2 infection during
pregnancy.
Perinatal COVID-19 Maternal and Neonatal Outcomes
at Two Academic Birth Hospitals
In utero fetal infection from
pregnant mothers with SARS-CoV-2 infection appears rare. Maternal/newborn
transmission during and immediately after delivery seems to occur with
greater frequency, and risk may be decreased with infection prevention
practices. This study sought to describe the relationship between perinatal
COVID-19 and maternal and newborn health outcomes, and our local incidence
of newborn SARS-CoV-2 infection during the delivery admission and within 1
month after birth, over a 13-month period at two urban, high-risk birth
hospitals.
|
No comments:
Post a Comment